About Avery Pharmaceuticals Private Limited
Data last updated:
Avery Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Arrow Greentech Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC295476. Its GSTIN is 27AAPCA6309L1Z8 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹71.45 Lakh. It is led by directors Shilpan Pravin Patel and Neil Shilpan Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 159 Mittal Industrial Estate Sanjay Building No 5/B Marol Naka Andheri (E), Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.83 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net loss of ₹4.74 Cr (net margin -258.8%) and EBITDA of -₹2.65 Cr (EBITDA margin -144.8%).
The company has about 41 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Avery Pharmaceuticals. As per MCA filings, the company has open charges of ₹3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website averypharma.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address159 Mittal Industrial Estate Sanjay Building No 5/B Marol Naka Andheri (E), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Avery Pharmaceuticals Private Limited
The main business activities of Avery Pharmaceuticals are manufacturing and financial and insurance service. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other financial activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| K | Financial and insurance Service | K8 | Other financial activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Avery Pharmaceuticals Private Limited FY 2025 filings available
Avery Pharmaceuticals Private Limited reported revenue of ₹1.83 Cr (up 42% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Avery Pharmaceuticals Private Limited
Revenue rose 42% in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Avery Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.65 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.74 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Avery Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -144.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -258.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Avery Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riya Exim Private Limited | ₹1.84 Cr (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Othantic Pharmaceuticals Private Limited | ₹1.84 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Indore, Madhya Pradesh, India |
| Vishnu Poly-Chems Private Limited | ₹1.84 Cr (FY 2019) | •••• | •••• | -15.0% | •••• | Solapur, Maharashtra, India |
| Glacial Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Thane, Maharashtra, India |
| Zochem Pharma Private Limited | ₹1.83 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Lucknow, Uttar Pradesh, India |
| Avery Pharmaceuticals Private Limited this company | ₹1.83 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
| Balasia Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Kolkata, West Bengal, India |
| Suzikem Drugs Private Limited | ₹1.83 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Hyderabad, Telangana, India |
| Nectar Laboratories Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | -76.0% | •••• | Hyderabad, Telangana, India |
| Palas Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Lucknow, Uttar Pradesh, India |
| Soin Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Thiruvananthapuram, Kerala, India |
Peers are the five companies nearest above and the five nearest below Avery Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals Private Limited is audited by R. A. Kuwadia & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R. A. Kuwadia & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shilpan Pravin Patel Also directs: Arrow Greentech Limited, Grace Paper Industries Pvt Ltd, Arrow Agri-Tech Private Limited and 4 more | Director | 29 May 2017 | 9 Years 4 Months | Current |
| Neil Shilpan Patel Also directs: Arrow Greentech Limited, Arrow Agri-Tech Private Limited, Arrow Business Advisory Private Limited and 3 more | Director | 29 May 2017 | 9 Years 4 Months | Current |
Ownership and Shareholding of Avery Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Avery Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2019 | Others | ₹3 Cr | Open |
Total charge records: 1 View all charges
MSME Payment Delays by Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record between 2020 and 2021, listing 13 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Thermolab Scientific Equipments Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Clean Air Engineers | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals operates one associated brand: Avery Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A specialty pharmaceutical company focusing on innovative drug delivery systems and patient care enhancements through Mouth Dissolving Strips technology. | averypharma.co.in |
Employees and EPFO Compliance at Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals Private Limited has a workforce of 41 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Avery Pharmaceuticals Private Limited
Recent Activity on Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Neil Shilpan Patel was appointed as Director on 29 May 2017.
Credit Ratings, Litigation & Regulatory Alerts for Avery Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Avery Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCA6309L1Z8 | Maharashtra | Active | 25 Aug 2017 |
| 24AAPCA6309L1ZE | Gujarat | Active | 13 Jun 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Avery Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avery Pharmaceuticals Private Limited
Avery Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U74999MH2017PTC295476.
Avery Pharmaceuticals reported revenue of ₹1.83 Cr for FY 2025 (up 42% YoY).
Avery Pharmaceuticals has 2 current directors:
- Shilpan Pravin Patel - Director
- Neil Shilpan Patel - Director
Avery Pharmaceuticals reported a net loss of ₹4.74 Cr (net margin -258.8%) and EBITDA of -₹2.65 Cr (EBITDA margin -144.8%) for FY 2025, as per its filed financial statements.
The GSTIN of Avery Pharmaceuticals is 27AAPCA6309L1Z8, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAPCA6309L1ZE (Gujarat).
The CIN (Corporate Identification Number) of Avery Pharmaceuticals is U74999MH2017PTC295476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avery Pharmaceuticals was incorporated on 29 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Avery Pharmaceuticals by revenue are Riya Exim Private Limited, Othantic Pharmaceuticals Private Limited, Vishnu Poly-Chems Private Limited, Glacial Pharmaceuticals Private Limited, Zochem Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Neil Shilpan Patel was appointed as Director on 29 May 2017. Shilpan Pravin Patel was appointed as Director on 29 May 2017.
Avery Pharmaceuticals has 3 MSME Form 1 returns on record between 2020 and 2021, listing 13 overdue payments to 8 micro and small suppliers. The latest return was filed on 13 May 2021.
Avery Pharmaceuticals can be reached through the website averypharma.co.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Avery Pharmaceuticals is at 159 Mittal Industrial Estate Sanjay Building No 5B Marol Naka Andheri E, Mumbai, Maharashtra, India – 400059.